ESMO Preceptorship on Gastrointestinal Tumours 2019: Singapore
- Start date
- 19 Nov 2019
- End date
- 21 Nov 2019
- Location
- Republic of Singapore
Learning objectives
- To learn about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings
- To understand the importance of pathology and histoprognostic factors
- To learn about the management of patients after progression, in special situations and side effects of treatments
- To learn about the management of unresectable/relapsing Hepatocellular Carcinoma and new approaches after failure of 1st line treatment
- To review the standard of care of anal carcinomas
- To learn the fundamental of epidemiology, aetiology, pathogenesis, molecular events and ethnic patterns as contributing factors to heterogeneity in gastric cancer
- To understand the essentials in the diagnosis and multidisciplinary treatment in gastric cancer
- To learn about the advances in the treatment and novel targets in gastric cancer
Accreditation
The programme of this event has been accredited with 13 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Andrés Cervantes, Spain
- Matthew C. H. Ng, Singapore